• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Nippon Med Sch . Comparison of IgG antibodies, SARS-CoV-2 load, and prognostic indicators in patients with severe and mild COVID-19 in Japan

tetano

Editor, Senior Moderator
J Nippon Med Sch


. 2020 Nov 30.
doi: 10.1272/jnms.JNMS.2021_88-417. Online ahead of print.
Comparison of IgG antibodies, SARS-CoV-2 load, and prognostic indicators in patients with severe and mild COVID-19 in Japan


Katsuhito Kashiwagi[SUP] 1 [/SUP], Tadashi Maeda[SUP] 1 [/SUP], Sadako Yoshizawa[SUP] 2 [/SUP], Takahiro Sato[SUP] 1 2 [/SUP], Kotaro Aoki[SUP] 2 [/SUP], Yoshikazu Ishii[SUP] 2 [/SUP], Kazuhiro Tateda[SUP] 2 [/SUP]



Affiliations

Abstract

We assessed the relationship between disease severity and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load, IgG antibody levels, and prognostic indicators. Twenty-one patients hospitalized with COVID-19 were classified as having severe or mild disease based on their average respiratory rate during hospitalization (severe: ≥22 breaths/min; mild: <22 breaths/min). The viral load in nasopharyngeal samples, and blood levels of C-reactive protein (CRP), lymphocytes, and D-dimer on admission and plasma immunoglobulin G (IgG) index on Day 7 ?2 from symptom onset were compared according to disease severity. Of the participants, 7 had severe and 14 had mild disease. Participants with severe disease had a significantly higher IgG index (median: 3.75 vs 0.56, p=0.01), CRP (median: 8.6 vs 1.0 mg/dL, p<0.001), and D-dimer levels (median: 1.65 vs 0.75μg/mL; p=0.002), and a significantly lower lymphocyte count (median: 1176 vs 666 cells/μL, p=0.005) and viral load (median: 8.7?10[SUP]6[/SUP] vs 2.3?10[SUP]4[/SUP] copies/mL, p=0.005). Furthermore, time from symptom onset to virus disappearance was significantly longer (median: 24 vs 17 days, p=0.03). A high IgG index in the early phase of the disease may be associated with disease severity and might serve as a prognostic indicator.

Keywords: COVID-19; IgG index; SARS-CoV-2; prognostic indicators; viral load.
 
Back
Top Bottom